Management of hepatotoxicity of chemotherapy and targeted agents

xlomafota13 shared this article with you from Inoreader Management of hepatotoxicity of chemotherapy and targeted agents Via American Journal of Cancer Research Am J Cancer Res. 2021 Jul 15;11(7):3461-3474. eCollection 2021. ABSTRACT Hepatotoxicity of chemotherapeutic agents such as methotrexate, oxaliplatin, and irinotecan have been well documented and characterized allowing for careful management by oncologists during administration. However, the rapid advance of the field of oncology and introduction of new classes of therapies such as small molecule inhibitors and immunotherapies have introduced new hepatotoxicity challenges and management strategies. This work is a compilation of the hepatotoxicity and recommended management of various chemotherapies and targeted agents, with a focus on the newer classes of targeted anticancer agents. PMID:34354855 | PMC:PMC8332851 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.